Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Molecular pathways: extracting medical knowledge from high-throughput genomic data.

Goldstein TC, Paull EO, Ellis MJ, Stuart JM.

Clin Cancer Res. 2013 Jun 15;19(12):3114-20. doi: 10.1158/1078-0432.CCR-12-2093. Epub 2013 Feb 21.

2.

Understanding genomic alterations in cancer genomes using an integrative network approach.

Wang E.

Cancer Lett. 2013 Nov 1;340(2):261-9. doi: 10.1016/j.canlet.2012.11.050. Epub 2012 Dec 22. Review.

PMID:
23266571
3.

Understanding the cancer cell phenotype beyond the limitations of current omics analyses.

Moreno-Sánchez R, Saavedra E, Gallardo-Pérez JC, Rumjanek FD, Rodríguez-Enríquez S.

FEBS J. 2016 Jan;283(1):54-73. doi: 10.1111/febs.13535. Epub 2015 Oct 27. Review.

4.

Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis.

Fang LT, Lee S, Choi H, Kim HK, Jew G, Kang HC, Chen L, Jablons D, Kim IJ.

Int J Oncol. 2014 Jan;44(1):211-21. doi: 10.3892/ijo.2013.2150. Epub 2013 Oct 25.

PMID:
24172857
5.

Identification of aberrant pathway and network activity from high-throughput data.

Ochs MF, Karchin R, Ressom H, Gentleman R.

Pac Symp Biocomput. 2011:364-8.

6.
7.

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling.

Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, Sachidanandam R, Sørlie T, Wärnberg F, Haakensen VD, Helland Å, Naume B, Perou CM, Haussler D, Troyanskaya OG, Børresen-Dale AL.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2802-7. doi: 10.1073/pnas.1108781108. Epub 2011 Sep 9.

8.

An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer.

Chari R, Coe BP, Vucic EA, Lockwood WW, Lam WL.

BMC Syst Biol. 2010 May 17;4:67. doi: 10.1186/1752-0509-4-67.

9.

Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.

Horlings HM, Lai C, Nuyten DS, Halfwerk H, Kristel P, van Beers E, Joosse SA, Klijn C, Nederlof PM, Reinders MJ, Wessels LF, van de Vijver MJ.

Clin Cancer Res. 2010 Jan 15;16(2):651-63. doi: 10.1158/1078-0432.CCR-09-0709. Epub 2010 Jan 12.

10.

A genomic strategy to elucidate modules of oncogenic pathway signaling networks.

Chang JT, Carvalho C, Mori S, Bild AH, Gatza ML, Wang Q, Lucas JE, Potti A, Febbo PG, West M, Nevins JR.

Mol Cell. 2009 Apr 10;34(1):104-14. doi: 10.1016/j.molcel.2009.02.030.

11.

Microarray tools for deciphering complex diseases.

Shai RM.

Front Biosci. 2006 May 1;11:1414-24. Review.

PMID:
16368525
13.

Genomic predictors of outcome and treatment response in breast cancer.

Dunn L, Demichele A.

Mol Diagn Ther. 2009;13(2):73-90. doi: 10.2165/01250444-200913020-00002. Review.

PMID:
19537843
14.

From cancer genomes to cancer models: bridging the gaps.

Baudot A, Real FX, Izarzugaza JM, Valencia A.

EMBO Rep. 2009 Apr;10(4):359-66. doi: 10.1038/embor.2009.46. Epub 2009 Mar 20. Review.

15.

Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.

Speer R, Wulfkuhle J, Espina V, Aurajo R, Edmiston KH, Liotta LA, Petricoin EF 3rd.

Cancer Genomics Proteomics. 2007 May-Jun;4(3):157-64. Review.

16.

Ovarian cancer: markers of response.

Na YJ, Farley J, Zeh A, del Carmen M, Penson R, Birrer MJ.

Int J Gynecol Cancer. 2009 Dec;19 Suppl 2:S21-9. doi: 10.1111/IGC.0b013e3181c2aeb5. Review.

PMID:
19955910
18.

Cancer genomics identifies disrupted epigenetic genes.

Simó-Riudalbas L, Esteller M.

Hum Genet. 2014 Jun;133(6):713-25. doi: 10.1007/s00439-013-1373-5. Epub 2013 Oct 9. Review.

PMID:
24104525
19.

Cancer omics: from regulatory networks to clinical outcomes.

Tang B, Hsu PY, Huang TH, Jin VX.

Cancer Lett. 2013 Nov 1;340(2):277-83. doi: 10.1016/j.canlet.2012.11.033. Epub 2012 Nov 29. Review.

PMID:
23201140
20.

Functional synergies yet distinct modulators affected by genetic alterations in common human cancers.

Bessarabova M, Pustovalova O, Shi W, Serebriyskaya T, Ishkin A, Polyak K, Velculescu VE, Nikolskaya T, Nikolsky Y.

Cancer Res. 2011 May 15;71(10):3471-81. doi: 10.1158/0008-5472.CAN-10-3038. Epub 2011 Mar 11.

Supplemental Content

Support Center